Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Methemoglobin-producing effect and its role in the mechanism of action of some radioprotective agents in the benzo-2,1,3-thiadiazole class. [Mice, dogs, gamma radiation]

Journal Article · · Radiobiology (USSR) (Engl. Transl.); (United States)
OSTI ID:6830061

A study was made of some derivatives of benzo-2,1,3-thiadiazole with regard to their capacity to form methemoglobin in blood. It was demonstrated that, 30 min after intraperitoneal administration of radioprotective doses of such agents to mice, the blood methemoglobin level does not exceed 5 percent. With administration to mice of 4-aminobenzo-2,1,3-thiadiazole in a toxic dose 14 percent methemoglobin is produced in blood. In dogs, almost 50 percent methemoglobin is formed in blood after oral intake of 4-aminobenzo-2,1,3-thiadiazole; this is a level that can provide for the radioprotective action of this compound. Using agents that prevent oxidation of hemoglobin to methemoglobin (2-methoxy-9-phenazine sulfate and isonicotinic acid hydrazide), it was demonstrated that the methemoglobin formed in mouse blood does not play a leading role in manifestation of the radioprotective action and toxic properties of 4-aminobenzo-2,1,3-thiadiazole.

OSTI ID:
6830061
Journal Information:
Radiobiology (USSR) (Engl. Transl.); (United States), Journal Name: Radiobiology (USSR) (Engl. Transl.); (United States) Vol. 17:6; ISSN RADBA
Country of Publication:
United States
Language:
English